The A, B, C and Double D’s of Healthy Breasts

By on May 30, 2017

Let’s face it ladies. Whether your cup size is an A, B, or double-D, we’re all at risk of the Big C – breast cancer. So, what can you do to keep your girls protected? Fortunately, Canada is leading the world in research and scientific advances to improve survival rates. But, new leading edge nutraceutical research is also showing having an actionable and preventative maintenance strategy may also play an important role.

Get Full Support 
A new generation of natural health products are emerging to help promote healthy breast tissue, and detoxify harmful estrogens in the body from birth control pills, hormone replacement therapies and estrogen from plastics. Even estrogens created by your own body can become harmful, if they aren't processed properly.

a product shot of femMED Breast Health

femMED's Breast Health formula has undergone clinical testing that shows consistent use of the product can favourably influence whether estrogen in the body takes a “beneficial” or a “disease-potential” path, by promoting healthy estrogen metabolism and supporting a healthy estrogen metabolite ratio. In a double-blind, placebo-controlled study conducted with Canadian women at Nutrasouce Diagnostics Inc. in Guelph, Ontario, Breast Health was shown to increase levels of 2-hydroxy estrone in just 28 days! Nutrasouce Diagnostics Inc is an independent, full-service contract research organization (CRO) specializing in regulatory consulting, clinical trials and product testing for the natural health industry. 

Why Promote a Healthy Estrogen Balance?
A current body of research (1,2,3,4,5,6,7) indicates that when levels of 16-hydroxy estrone decrease and levels of 2-hydroxy estrone increase, then the risk for breast cancer decreases. In a second larger study on Breast Health's key ingredient, indole-3 carbinol (I3C), a substance naturally occurring in broccoli, cabbage and Brussels sprouts, 13,000 Italian women were followed for over 10 years. They also had the same estrogen metabolite ratio as women on femMED Breast Health, at the same dosage8.  Breast Health is also clinically proven to reduce cyclical breast pain and tenderness. 

igen logo informed GMO Choice

Only The Good 
femMED believes that source matters. That's why femMED Breast Health is 3rd party tested for the absence of genetic engineering with IGEN™ (the International GMO Evaluation and Notification Program). IGEN is the first formal certification program that tests finished products and its ingredients to determine if genetic engineering is present in, or was used in the production of the product. The IGEN™ Program evaluates the GMO content of samples using validated analytical methods. Visit www.igenprogram.com for full transparency on testing results. femMED Breast Health is a natural breast health supplement formula that has been clinically tested in women, and is patent pending. femMED Breast Health does not contain soy, yeast, or gluten, and does not contain artificial flavours, colours or fillers, only the good. 

Visit www.femmedbreasthealth.com for more information. femMED Breast Health is authorized by Health Canada with natural product number (NPN) 80039359. 

References:
1. Kabat GC, Chang CJ, Sparano JA, et al. Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiology, Biomarkers and Prevention. 1997;6:505–9.

2. Muti P, Bradlow HL, Micheli A, et al. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16α-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology. 2000;11(6): 635–40.

3. Lord RS, Bongiovanni B, Bralley JA. Estrogen metabolism and the diet-cancer connection: rationale for assessing the ratio of urinary hydroxylated estrogen metabolites. Alternative Medicine Review. 2002;7(2):112–29.

4. Okobia MN, Bunker CH. Estrogen metabolism and breast cancer risk—a review. Afr J Reprod Health. 2006;10(1):13–25.

5. Kabat GC, O’Leary ES, Gammon MD, et al. Estrogen metabolism and breast cancer. Epidemiology. 2006;17(1):80–8.

6. Sepkovic DW, Bradlow HL. Estrogen hydroxylation—the good and the bad. Ann N Y Acad Sci. 2009;1155:57–67.

7. Im A, Vogel VG, Ahrendt G, et al. Urinary estrogen metabolites in women at high risk for breast cancer. Carcinogenesis. 2009;30(9):1532–5.

8. Paola Muti,1,2 H. Leon Bradlow et al. Estrogen Metabolism and Risk of Breast Cancer: A Prospective Study of the 2:16!-Hydroxyestrone Ratio in Premenopausal and Postmenopausal Women. Epidemiology. 2000;11 (6).

About Charleen Wyman

Leave a Reply

Your email address will not be published. Required fields are marked *